Recipient hepatectomy technique may affect oncological outcomes of liver transplantation for hepatocellular carcinoma

医学 肝细胞癌 肝切除术 肝移植 米兰标准 胃肠病学 移植 肝病 内科学 外科 泌尿科 切除术
作者
Riccardo Pravisani,Maria De Martino,Federico Mocchegiani,Fabio Melandro,Damiano Patrono,Andrea Lauterio,Fabrizio di Francesco,Matteo Ravaioli,M. Zambelli,Claudio Bosio,Daniele Dondossola,Quirino Lai,Matteo Zanchetta,Jule Dingfelder,Luca Toti,Alessandro Iacomino,Sermed Nicolae,Davide Ghinolfi,Renato Romagnoli,Luciano De Carlis,Salvatore Gruttadauria,Matteo Cescon,M. Colledan,Amedeo Carraro,L. Caccamo,Marco Vivarelli,Massimo Rossi,Silvio Nadalin,Georg Györi,Giuseppe Tisone,Giovanni Vennarecci,Andreas Arendtsen Rostved,Paolo De Simone,Miriam Isola,Umberto Baccarani
出处
期刊:Liver Transplantation [Wiley]
卷期号:30 (10): 1002-1012 被引量:1
标识
DOI:10.1097/lvt.0000000000000373
摘要

To date, caval sparing (CS) and total caval replacement (TCR) for recipient hepatectomy in liver transplantation (LT) have been compared only in terms of surgical morbidity. Nonetheless, the CS technique is inherently associated with an increased manipulation of the native liver and later exclusion of the venous outflow, which may increase the risk of intraoperative shedding of tumor cells when LT is performed for HCC. A multicenter, retrospective study was performed to assess the impact of recipient hepatectomy (CS vs. TCR) on the risk of posttransplant HCC recurrence among 16 European transplant centers that used either TCR or CS recipient hepatectomy as an elective protocol technique. Exclusion criteria comprised cases of non-center–protocol recipient hepatectomy technique, living-donor LT, HCC diagnosis suspected on preoperative imaging but not confirmed at the pathological examination of the explanted liver, HCC in close contact with the IVC, and previous liver resection for HCC. In 2420 patients, CS and TCR approaches were used in 1452 (60%) and 968 (40%) cases, respectively. Group adjustment with inverse probability weighting was performed for high-volume center, recipient age, alcohol abuse, viral hepatitis, Child-Pugh class C, Model for End-Stage Liver Disease score, cold ischemia time, clinical HCC stage within Milan criteria, pre-LT downstaging/bridging therapies, pre-LT alphafetoprotein serum levels, number and size of tumor nodules, microvascular invasion, and complete necrosis of all tumor nodules (matched cohort, TCR, n = 938; CS, n = 935). In a multivariate cause-specific hazard model, CS was associated with a higher risk of HCC recurrence (HR: 1.536, p = 0.007). In conclusion, TCR recipient hepatectomy, compared to the CS approach, may be associated with some protective effect against post-LT tumor recurrence.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
哆啦A涵发布了新的文献求助10
2秒前
out_2025发布了新的文献求助10
2秒前
zy完成签到 ,获得积分10
2秒前
思源应助111采纳,获得10
2秒前
cyj完成签到 ,获得积分10
2秒前
3秒前
可乐完成签到,获得积分10
3秒前
3秒前
3秒前
科研通AI2S应助火山羊采纳,获得10
3秒前
杨春天完成签到,获得积分10
4秒前
感动新烟完成签到 ,获得积分10
4秒前
4秒前
zidan007完成签到,获得积分10
4秒前
5秒前
NexusExplorer应助ZZZ采纳,获得10
5秒前
明理妙柏完成签到,获得积分10
6秒前
TiAmo发布了新的文献求助10
6秒前
Fayth完成签到,获得积分10
6秒前
轩辕乌完成签到,获得积分10
6秒前
彼岸花完成签到,获得积分10
6秒前
叶子完成签到 ,获得积分10
6秒前
青椒肉丝完成签到,获得积分10
7秒前
Owen应助苹果惜梦采纳,获得10
7秒前
perper发布了新的文献求助10
8秒前
ylw完成签到,获得积分20
8秒前
8秒前
8秒前
9秒前
遇安发布了新的文献求助10
9秒前
9秒前
戴哈哈完成签到 ,获得积分10
10秒前
阔达故事完成签到,获得积分10
10秒前
Bgeelyu发布了新的文献求助10
10秒前
677完成签到,获得积分10
10秒前
yeah完成签到,获得积分10
10秒前
wym发布了新的文献求助10
11秒前
科研大白完成签到,获得积分10
11秒前
慎独而已完成签到,获得积分10
11秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Востребованный временем 2500
Aspects of Babylonian celestial divination : the lunar eclipse tablets of enuma anu enlil 1500
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3450912
求助须知:如何正确求助?哪些是违规求助? 3046469
关于积分的说明 9006430
捐赠科研通 2735191
什么是DOI,文献DOI怎么找? 1500195
科研通“疑难数据库(出版商)”最低求助积分说明 693433
邀请新用户注册赠送积分活动 691683